MillerKnoll
MLKN
20.65
-0.07
-0.34%
MillerKnoll
US · MLKN
#3035 by market cap
Listed 1970
20.65
-0.07
-0.34%
Live - 5344 symbols - heartbeat 352s ago
· 2026-10-07 19:54
After-hours
20.65
0.00%
- Market cap
- 1.42B
- P/E (TTM)i
- 14.65
- P/Bi
- 1.05
- EPSi
- 1.32
- Div yieldi
- 3.63%
- 52W posi
- 66%
Reader sentiment
Are you bullish or bearish on MLKN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 1.83, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.68% YoY
Margins
- Gross margin
- 38.75%
- Operating margin
- 5.47%
- Net margin
- 2.38%
Key ratios & quality
- Enterprise valuei
- 2.62B
- PEG ratioi
- 0.50
- Altman Z-Scorei
- 1.83
PEG uses trailing P/E against the 3-year net income growth rate (29.53%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.57B | 2.49B | 2.47B | 3.95B | 4.09B | 3.63B | 3.67B | 3.84B |
| Gross profit | 929.90M | 911.20M | 951.10M | 1.35B | 1.43B | 1.42B | 1.42B | 1.49B |
| Selling & admin expenses | 639.30M | 643.30M | 643.80M | 1.20B | 1.13B | 1.11B | 1.13B | 1.18B |
| Research & development | 76.90M | 74.00M | 72.10M | 108.70M | 105.70M | 92.60M | 93.80M | 100.30M |
| Operating profit | 213.70M | 193.90M | 235.20M | 39.80M | 197.90M | 214.80M | 195.30M | 210.20M |
| Pretax profit | 195.10M | -12.90M | 228.30M | -8.60M | 51.40M | 99.70M | -21.90M | 128.20M |
| Tax | 39.60M | 6.10M | 48.30M | 11.10M | 4.50M | 14.70M | 11.60M | 32.40M |
| Net profit | 160.50M | -14.00M | 180.30M | -19.70M | 46.10M | 84.60M | -33.20M | 95.70M |
| Basic EPS | 3 | 0 | 3 | 0 | 1 | 1 | -1 | 1 |
| Diluted EPS | 2.70 | -0.15 | 2.94 | -0.37 | 0.55 | 1.11 | -0.54 | 1.32 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 961.80M | 955.70M | 955.20M | 926.60M | 1.00B | 923.40M |
| Gross profit | 376.90M | 368.10M | 372.20M | 352.90M | 395.60M | 385.30M |
| Selling & admin expenses | 287.10M | 293.80M | 298.30M | 285.50M | 300.70M | 302.50M |
| Research & development | 24.20M | 20.30M | 24.00M | 20.60M | 35.40M | 25.00M |
| Operating profit | 65.60M | 54.00M | 49.90M | 46.80M | 59.50M | 57.80M |
| Pretax profit | 35.70M | 28.70M | 32.50M | 29.20M | 37.80M | 35.20M |
| Tax | 91.90M | 7.60M | 7.30M | 5.60M | 11.90M | 7.60M |
| Net profit | -56.20M | 21.10M | 25.20M | 24.50M | 24.90M | 27.60M |
| Basic EPS | -1 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.84 | 0.29 | 0.35 | 0.34 | 0.34 | 0.38 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 661.30M | 917.10M | 906.50M | 1.32B | 1.18B | 1.07B | 1.11B | 1.14B |
| Cash & ST investments | 168.00M | 461.00M | 404.10M | 230.30M | 223.50M | 230.40M | 193.70M | 167.70M |
| Inventory | 184.20M | 197.30M | 228.60M | 587.30M | 487.40M | 428.60M | 447.50M | 488.40M |
| Total assets | 1.57B | 2.05B | 2.08B | 4.51B | 4.27B | 4.04B | 3.95B | 4.00B |
| Total current liabilities | 446.10M | 470.20M | 476.50M | 877.40M | 702.80M | 697.70M | 703.80M | 721.10M |
| Short-term debt | 3.10M | 51.40M | 47.00M | 109.20M | 110.50M | 110.70M | 88.00M | 107.10M |
| Long-term debt | 281.90M | 539.90M | 274.90M | 1.38B | 1.37B | 1.29B | 1.31B | 1.26B |
| Total liabilities | 829,500,000.00 | 1,360,500,000.00 | 1,139,300,000.00 | 2,980,000,000.00 | 2,734,600,000.00 | 2,584,600,000.00 | 2,615,100,000.00 | 2,594,600,000.00 |
| Total equity | 739.80M | 693.40M | 937.50M | 1.53B | 1.54B | 1.46B | 1.34B | 1.41B |
| Retained earnings | 712.70M | 683.90M | 819.30M | 693.30M | 676.10M | 738.40M | 665.10M | 704.00M |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 1.11B | 1.09B | 1.12B | 1.12B | 1.14B | 1.14B |
| Cash & ST investments | 193.70M | 167.20M | 180.40M | 174.60M | 167.70M | 178.60M |
| Inventory | 447.50M | 465.80M | 477.80M | 491.80M | 488.40M | 514.70M |
| Total assets | 3.95B | 3.94B | 3.95B | 3.95B | 4.00B | 4.00B |
| Total current liabilities | 703.80M | 652.00M | 671.70M | 682.10M | 721.10M | 692.30M |
| Short-term debt | 88.00M | 92.10M | 98.50M | 103.60M | 107.10M | 110.10M |
| Long-term debt | 1.31B | 1.33B | 1.32B | 1.28B | 1.26B | 1.27B |
| Total liabilities | 2,615,100,000.00 | 2,578,600,000.00 | 2,583,600,000.00 | 2,553,200,000.00 | 2,594,600,000.00 | 2,582,900,000.00 |
| Total equity | 1.34B | 1.36B | 1.36B | 1.40B | 1.41B | 1.42B |
| Retained earnings | 665.10M | 672.90M | 684.20M | 694.40M | 704.00M | 717.70M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 216.40M | 221.80M | 332.30M | -11.90M | 162.90M | 352.30M | 209.30M | 199.90M |
| Depreciation & amortization | 72.10M | 79.50M | 87.20M | 190.60M | 155.10M | 155.10M | 140.50M | 148.30M |
| Free cash flow | 125.80M | 152.80M | 272.50M | -106.60M | 79.60M | 273.90M | 101.70M | 77.60M |
| Dividends paid | -45.60M | -36.40M | -34.50M | -54.50M | -57.10M | -55.60M | -51.70M | -51.10M |
| Stock buybacks / issuance | -35.60M | -11.00M | 4.10M | -8.70M | -10.50M | -132.30M | -78.90M | 31.10M |
| Ending cash balance | 159.20M | 454.00M | 396.40M | 230.30M | 223.50M | 230.40M | 193.70M | 167.70M |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | 70.90M | 9.40M | 64.60M | 61.10M | 64.80M | 49.10M |
| Depreciation & amortization | 35.90M | 35.40M | 36.60M | 38.10M | 38.20M | 34.50M |
| Free cash flow | 31.40M | -21.30M | 34.00M | 39.00M | 25.90M | 16.60M |
| Dividends paid | -12.70M | -12.70M | -12.90M | -12.70M | -12.80M | -12.80M |
| Stock buybacks / issuance | 700.00K | -6.30M | 50.00M | 18.00M | -30.60M | 8.70M |
| Ending cash balance | 193.70M | 167.20M | 180.40M | 174.60M | 167.70M | 178.60M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 23.20 | -1.34 | 23.19 | -2.38 | 2.94 | 5.84 | -2.77 | 6.99 |
| ROA %i | 10.53 | -0.50 | 8.41 | -0.82 | 0.96 | 1.98 | -0.92 | 2.30 |
| ROIC %i | 17.36 | -0.13 | 13.33 | -0.01 | 3.24 | 4.40 | 0.52 | 4.51 |
| 5-year avg ROE %i | 23.91 | 18.72 | 17.58 | 12.65 | 9.14 | 5.67 | 5.37 | 2.13 |
| EBIT margin %i | 8.07 | -0.04 | 9.75 | 0.74 | 3.07 | 4.85 | 1.49 | 5.16 |
| FCF / sales %i | 4.90 | 6.14 | 11.05 | -- | 1.95 | 7.55 | 2.77 | 2.02 |
| Current ratioi | 1.48 | 1.95 | 1.90 | 1.50 | 1.67 | 1.53 | 1.58 | 1.58 |
| Quick ratioi | 0.94 | 1.40 | 1.31 | 0.70 | 0.84 | 0.80 | 0.81 | 0.75 |
| Debt / assetsi | 18.16 | 37.49 | 26.15 | 41.79 | 43.73 | 43.59 | 45.87 | 45.03 |
| LT debt / equityi | 39.20 | 111.77 | 57.64 | 124.55 | 122.77 | 119.28 | 135.13 | 126.20 |
| Interest coveragei | 17.12 | -0.07 | 17.29 | 0.77 | 1.69 | 2.31 | 0.71 | 2.83 |
| Revenue CAGR (3Y) %i | 4.26 | 2.96 | 1.16 | 15.41 | 18.01 | 13.75 | -2.39 | -2.04 |
| Net income CAGR (3Y) %i | 5.50 | -- | 10.87 | -- | -- | -22.18 | -- | 29.53 |
| FCF CAGR (3Y) %i | 0.13 | 10.00 | 41.64 | -- | -19.54 | 0.17 | -- | -0.84 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | -2.77 | -1.18 | -1.95 | 0.83 | 6.99 | 7.37 |
| ROA %i | -0.92 | -0.39 | -0.64 | 0.28 | 2.30 | 2.46 |
| ROIC %i | 0.52 | 1.17 | 0.82 | 1.64 | 4.51 | 4.64 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 1.49 | 2.22 | 1.84 | 5.18 | 5.16 | 5.31 |
| FCF / sales %i | 2.77 | 2.18 | 2.21 | 2.19 | 2.02 | 3.03 |
| Current ratioi | 1.58 | 1.67 | 1.67 | 1.64 | 1.58 | 1.65 |
| Quick ratioi | 0.81 | 0.82 | 0.81 | 0.76 | 0.75 | 0.76 |
| Debt / assetsi | 45.87 | 46.40 | 46.12 | 45.10 | 45.03 | 45.48 |
| LT debt / equityi | 135.13 | 133.63 | 132.46 | 125.69 | 126.20 | 126.13 |
| Interest coveragei | 0.71 | 1.11 | 0.95 | 2.78 | 2.83 | 2.99 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- North America Contract is the largest reported line at 54.75% of revenue, across 3 reported segments.
- Global Retail follows at 28.27%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
North America Contract54.75%
Global Retail28.27%
International Contract16.98%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.